SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharmaceuticals informs about company updates

01 Jun 2016 Evaluate

Glenmark Pharmaceuticals has informed that in furtherance to the notice issued by the Company on May 31, 2016 announcing the launch of the FCCBs, the Company has entered into a Subscription Agreement dated May 31, 2016 with J.P. Morgan Securities plc (the book running lead manager to the Issue). In terms of the Subscription Agreement, the Company will issue the FCCBs at 100% of their principal amount on or about June 28, 2016 (Closing Date).

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2244.20 -3.70 (-0.16%)
20-Apr-2026 11:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1677.10
Dr. Reddys Lab 1238.10
Cipla 1238.70
Zydus Lifesciences 942.95
Lupin 2327.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×